InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-56.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Session R.A. II. Director active across 1 company, notably Taysha Gene Therapies, Inc.. In total, 5 filings have been published. Split: 1 buy · 3 sells. Total volume traded: €428k. Activity tracked since 23 November 2021. The latest transaction was filed on 12 July 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Session R.A. II
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
80,528 shares@ US$0.70828.4% of flowCommon StockSEC:0000950170-23-032986:0
10,508 shares@ US$0.70271.1% of flowCommon StockSEC:0000899243-23-016491:0
295,653 shares@ US$0.71131.7% of flowCommon StockSEC:0000899243-23-016232:0
251,296 shares0Common StockSEC:0001209191-23-017342:0
16,510 shares@ US$12.1241.5% of flowCommon StockSEC:0001209191-21-068510:0
Canonical exit: 21 Feb 2022 (T+90)
5 of 5 declarations
About Session R.A. II
Session R.A. II is a declarant linked to Taysha Gene Therapies, Inc. (XNAS). It has made 6 filings in total, and, within the sampled recent filings, the buy and sell amounts are EUR 355984 and EUR 250404 respectively, over the period from 2021-12-08 to 2023-07-14, with the modal transaction nature indicated as Sell.
